NDC 61703-332
Bleomycin 15 [USP'U] injection, powder, lyophilized, for solution
On the label: Hospira, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Hospira Oncology Private Limited | Ahmedabad, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyJun 30, 2023 · 5 inspections |
Recalls
- Dec 21, 2023 · Class I · Pfizer
Presence of particulate matter: glass
Lots: Lot #: BL12206A, Exp date 06/30/2024
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bleomycin: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intramuscular; intrapleural; intravenous; subcutaneous
- Strength
- 15 [USP'U]
- Approval
- ANDA ANDA065031
- On the market since
- Apr 11, 2000
- Package NDCs
61703-332-18- Official label
- DailyMed (National Library of Medicine), updated Aug 25, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?